-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CpeONI7jvB3wQxgOVcCevKrjq2lRivfIBhcKeW4PuSFzehsIDse7hDddSCBEP3yz DHp1Am439f2LZQiafBx2XQ== 0000950117-02-001999.txt : 20020822 0000950117-02-001999.hdr.sgml : 20020822 20020821183827 ACCESSION NUMBER: 0000950117-02-001999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020813 FILED AS OF DATE: 20020822 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MONSANTO CO /NEW/ CENTRAL INDEX KEY: 0001110783 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 431878297 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16167 FILM NUMBER: 02745217 BUSINESS ADDRESS: STREET 1: 800 N LINDBERGH BLVD CITY: ST LOUIS STATE: MO ZIP: 63167 BUSINESS PHONE: 3146944296 MAIL ADDRESS: STREET 1: 800 NORTH LINDBERGH BLVD CITY: ST LOUIS STATE: MO ZIP: 63167 COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] OWNER IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 4 1 a33258.txt PHARMACIA CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 - --------------------------------- --------------------------------- FORM 4 OMB APPROVAL - --------------------------------- --------------------------------- OMB Number: 3235-0287 [X] Check this box if no longer Expires: January 31, 2005 subject to Section 16. Form 4 Estimated average burden or Form 5 obligations may hours per response..........1.0 continue. See Instruction 1(b). --------------------------------- (Print or Type Responses) - ---------------------------------------------------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol Pharmacia Corporation Monsanto Company (MON) - ---------------------------------------------------------------------------------------------------------------------------- (Last) (First) (Middle) 3. I.R.S. Identification 4. Statement for Number of Reporting Month/Year Person, if an entity 100 Route 206 North (Voluntary) August 2002 - -------------------------------------------------- --------------------------------- (Street) 5. If Amendment, Date of Peapack NJ 07977 Original (Month/Year) - -------------------------------------------------- (City) (State) (Zip) - ---------------------------------------------------------------------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner --- --- Officer (give Other (specify --- title below) --- below) - ---------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) X Form Filed by One Reporting Person --- Form Filed by More than One Reporting Person --- - ----------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------- Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ----------------------------------------------------------------------------------------------------------- 1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) (Instr. 3) action action or Disposed of (D) Date Code (Instr. 3, 4 and 5) (Instr. 8) (Month/ ------------------------------------------------------ Day/ Year) Amount (A) or Code V (D) Price - ----------------------------------------------------------------------------------------------------------- Common Stock 8/13/02 J(1) 220,000,000 D -- - ----------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------- 5. Amount of 6. Owner- 7. Nature of Securities Bene- ship Indirect ficially Owned Form: Beneficial at End of Direct Owner- Month (D) or ship Indirect (Instr. 3 and 4) (I) (Instr. 4) (Instr. 4) - ------------------------------------------------------------- 0 D -- - ------------------------------------------------------------- - ------------------------------------------------------------- - ------------------------------------------------------------- - ------------------------------------------------------------- - -------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see (Over) Instruction 4(b)(v). SEC 1474 (7-97) FORM 4 (continued) Table II-- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
- -------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative 2. Conver- 3. Trans- 4. Transac- 5. Number of Deriv- 6. Date Exer- Security sion or action tion Code ative Securities Ac- cisable and Ex- (Instr. 3) Exercise Date (Instr. 8) quired (A) or Dis- piration Date Price of posed of (D) (Month/Day/ Deriv- (Month/ (Instr. 3, 4, and 5) Year) ative Day/ Security Year) ------------------------------------------------------------------ Date Expira- Exer- tion Code V (A) (D) cisable Date - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------- 7. Title and Amount of Under- 8. Price 9. Number 10. Owner- 11. Nature lying Securities of of ship of (Instr. 3 and 4) deriv- Deriv- Form of Indirect ative ative Deriv- Benefi- Secu- Secu- ative cial rity rities Secu- Owner- - ------------------------------ (Instr. 5) Bene- rity: ship ficially Direct (Instr. 4) Owned (D) or at End Indi- of rect(I) Month (Instr. 4) (Instr. 4) Title Amount or Number of Shares - ----------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------- - -----------------------------------------------------------------------------------------------
Explanation of Responses: (1) On August 13, 2002, Pharmacia Corporation (NYSE: PHA) ("Pharmacia") spun-off its remaining interest in its agricultural subsidiary, Monsanto Company (NYSE: MON) ("Monsanto"), to the holders of Pharmacia common stock. The spin-off was effected by a special stock dividend, in the aggregate, of 220,000,000 shares of Monsanto common stock resulting in a distribution ratio of 0.170593 of a share of Monsanto common stock for each outstanding share of Pharmacia common stock. The dividend was paid on August 13, 2002 to holders of record of shares of Pharmacia common stock that were issued and outstanding as of 5:00 p.m. Eastern time on July 29, 2002, the record date. **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. /s/ Don W. Schmitz 08/21/02 ----------------------------------- -------------- **Signature of Reporting Person Date Don W. Schmitz Vice President and Secretary Pharmacia Corporation Page 2 of 2 SEC 1474 (7-97) (Print or Type Response) -----END PRIVACY-ENHANCED MESSAGE-----